OrthoPediatrics Corp. (NASDAQ: KIDS) is a Healthcare company (Medical - Devices) with a market capitalization of $820M. The Maz Rating grades it against the other companies in its sector.
OrthoPediatrics Corp.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $31.41, OrthoPediatrics Corp. trades at 3.1x sales and 2.2x book value, with an EV/EBITDA of 369.7. Over the last twelve months it generated about $266M of revenue and a net loss of $38M. It runs a gross margin of 73.8%, an operating margin of -8.4% and a net margin of -12.8%. It shows return on equity of -9.9%, return on invested capital of -4.9% and a free cash flow yield of 0.4%. On the balance sheet: a debt-to-equity ratio of 0.29 and a current ratio of 4.55. Over the past 52 weeks the share price ranged from $14.42 to $34.53, with a beta of 0.87.
OrthoPediatrics Corp. does not currently pay a dividend.
15 Wall Street analyst ratings cover the stock: 14 Buy and 1 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
Yes. As of September 2026, OrthoPediatrics Corp. (KIDS) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 16.3% / 30% · (Cash+Inv) / Mkt Cap (36m) 7.35% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 16.3% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 7.35% / 33% · Receivables / Mkt Cap (36m) 9.89% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 16.3% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 7.35% / 33.33% · Receivables / Mkt Cap (24m) 9.89% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 19.5% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 9.94% / 33.33% · Receivables / Avg Assets (4Q) 11.3% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| FTSE | Debt / Total Assets 19.3% / 33.33% · (Cash+ST Inv) / Total Assets 8.69% / 33.33% · (Cash+Recv) / Total Assets 20.4% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
Yes. As of September 2026, OrthoPediatrics Corp. (KIDS) is classified as HALAL by Maz Vantage: it passes all 5 published Shariah screening standards it was tested against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
Yes. OrthoPediatrics Corp. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
OrthoPediatrics Corp. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.